Skip to main content

Year: 2022

ACM Research Expands into Chemical Vapor Deposition Market to Support Logic & Memory Manufacturing

FREMONT, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) — ACM Research, Inc. (ACM) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging (WLP) applications, today, through its operating subsidiary ACM Research (Shanghai), Inc., announced the introduction of its Ultra PmaxTM Plasma-Enhanced Chemical Vapor Deposition (PECVD) tool, marking ACM’s entry into another major new product category. ACM expects to ship its first PECVD evaluation tool to a China-based customer in the next few weeks. “Our Ultra PmaxTM PECVD tool marks expansion into another new process area of front-end semiconductor manufacturing,” said Jian Wang, CEO of ACM Research (Shanghai), Inc. “Many of our customers are 28nm and above logic device providers. We anticipate a need to increase capacity at more mature...

Continue reading

Provectus Biopharmaceuticals Announces Decision to Not Undertake Reverse Split of Outstanding and Authorized Equities in 2022; Expects to Seek Same Stockholder Approval Again in 2023

KNOXVILLE, TN, Dec. 12, 2022 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced that the Company’s Board of Directors (Board) has decided to not undertake the reverse stock split and authorized share reduction, which Provectus stockholders approved at the Company’s 2022 Annual Meeting of Stockholders, by the approved date of December 31, 2022. Ed Pershing, Chair of Provectus’ Board said, “The Board assessed the prospective factors that it reasonably believed would be necessary to support the potential successful follow-through from undertaking a reverse stock split, and that could also potentially mitigate negative capital markets behavior.” Mr. Pershing added, “The Board ultimately concluded that it would be in the best interests of the Company’s stockholders to not undertake the reverse stock split and authorized share...

Continue reading

Society Pass (Nasdaq: SOPA) to Present at the #Adapt International Convention 2022 on 13-14 December 2022

Society Pass Incorporated #Adapt International Convention 2022SINGAPORE, Dec. 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Society Pass Incorporated (“SoPa”) (Nasdaq: SOPA), Southeast Asia’s (SEA) leading data-driven loyalty, fintech and e-commerce ecosystem, today announces that Company Founder, Chairman, and CEO Dennis Nguyen has been invited to present at the #Adapt International Convention 2022, to be virtually held on Tuesday, 13 December 2022 and Wednesday, 14 December 2022. The title of the conference is “A New Age: Unraveling the Future of Metaverse, AI and Digital Assets”. In Keynote #6 address in Room 2, Mr. Nguyen will present “Digital Assets In The Web3 Economy. Society Points Are Digital Assets” at 2:30 pm on Tuesday, 13 December 2022. If you would like to listen to the Company’s presentation, please click...

Continue reading

A.I.S. Resources Reports Visible Gold at its Bright Project in Victoria, Australia

Figure 1 Visible gold and sulphide intersection in GBDD003 at 75.5mFigure 2 Section across GBDD003, looking north-westFigure 3 Regional tenement and surface geologyFigure 4 Prospect map of EL6194VANCOUVER, British Columbia, Dec. 12, 2022 (GLOBE NEWSWIRE) — A.I.S. Resources Limited (TSX.V: AIS, OTCQB: AISSF) (the “Company” or “AIS”) announces that the Company intersected visible gold (Figure 1) at the Golden Bar Prospect in the third hole of its current 1,500 meter program to test widths, grades and association between the Shaws, Red, Leader, Home, and Golden Bar reef systems. Figure 1: Visible gold and sulphide intersection in GBDD003 at 75.5mhttps://www.globenewswire.com/NewsRoom/AttachmentNg/23f4ef63-352a-4f59-bee1-2c3fe7e846c9 Visible Gold at Hole GBDD003The third hole (GBDD003) intersected gold in a spurry quartz-carbonate...

Continue reading

Clene Announces Closing of $5 Million Debt Facility from the State of Maryland

Funding Demonstrates Importance of Working with Private Sector to Improve Lives of Marylanders, says Governor Hogan SALT LAKE CITY, Dec. 12, 2022 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced the closing of a $5 million debt facility (the “Loan”) with the Maryland Department of Housing and Community Development (“DHCD”). The State Small Business Credit Initiative (“SSBCI”) program within DHCD sourced the funds for the Loan from the U.S. Department of Treasury. All conditions related to the Loan were satisfied by Clene. The Loan bears interest at a rate of 6% per annum and has a maturity date 60 months from the...

Continue reading

Mass Megawatts Announces the Opening of a Marlborough, Massachusetts Sales Office

WORCESTER, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) — Mass Megawatts (OTC: MMMW) www.massmegawatts.com  announces the opening of a sales office in a fast growing and high tech location near central Massachusetts. The Office located at 11 Apex Drive, Suite 300A, Marlborough, MA is near Route 495 and minutes away from the Mass Pike. Mass Megawatts is expanding its reach to potential customers with recent developments like the opening of the sales office and recent improvements to bring more efficiency toward acquiring customers and installing projects.  Mass Megawatts can help customers achieve a quick payback with its solar projects using the new patent pending solar tracker. The projects can pay for itself in three to five years at many locations in states like Massachusetts, New York and Connecticut. Most of the components of both...

Continue reading

UPDATE — Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.

SAN FRANCISCO, Dec. 12, 2022 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that it has granted an exclusive license to Ocular Therapeutix Inc. (“Ocular”) pertaining to certain patent applications for ophthalmic uses in both humans and nonhuman animals in the territory of the United States. Under the terms of the agreement, Ocular will pay Titan an upfront licensing fee with the potential for additional payments upon reaching certain milestones. Kate Beebe DeVarney, Ph.D., President and Chief Operating Officer of Titan Pharmaceuticals, commented, “We are pleased to enter into this licensing agreement with Ocular. Our team has been working hard to monetize our significant scientific assets. We believe our drug delivery technology can provide significant...

Continue reading

Residential Battery Market Size [2022-2029] | Industry Share, Growth, and Trends Forecast Analysis

Residential Battery Market to Escalate Progressively; Increasing Demand for Continuous Power Supply to Spur Opportunities, states Fortune Business Insights™ Pune, India , Dec. 12, 2022 (GLOBE NEWSWIRE) — The increasing demand for backup power can have a tremendous impact on the global market, states Fortune Business Insights, in a report, titled “Residential Battery Market Size, Share & Industry Analysis, By Type ( Lithium-ion battery, Lead-Acid battery, Others ), By Power Rating ( 3-6 kW, 6-10 kW ), By Operation ( Standalone, Solar ) and regional forecast 2020-2027.” The growing adoption of Li-ion batteries is expected to foster the healthy growth of the market. The report covers major growth trajectories of the market, including drivers, restraints, challenges, and opportunities of the market. Besides this, the report...

Continue reading

Tunnel Boring Machines Market Size [2022-2029] | Industry Share, Trends, and Growth Forecast Analysis

Global Tunnel Boring Machines Market to Grow with Rising Adoption of Mechanical Boring Machines for Coal Mining Operations: Fortune Business Insights™ Pune, India, Dec. 12, 2022 (GLOBE NEWSWIRE) — The global Tunnel Boring Machines Market size is slated to swell considerably as major economies ramp up their spending on infrastructure. Investment in infrastructural development provides indications about a nation’s economic health as these investments are considered vital to create employment opportunities. Emerging economies are intensely formulating policies and plans of action to attract investment in infrastructure projects. For instance, in December 2019, the Finance Minister of India announced that the government will be investing $1.5 trillion for infrastructure development in the country. The plan will include ongoing...

Continue reading

Centrifugal Pump Market Size Worth USD 45.56 Billion by 2028 | Exhibiting CAGR of 5.9%

According to Fortune Business Insights, the global Centrifugal Pump market size is projected to grow from USD 29.24 Billion in 2020 to USD 45.56 Billion in 2028, at CAGR of 5.9% during forecast period. Pune, India, Dec. 12, 2022 (GLOBE NEWSWIRE) — The global centrifugal pump market size is projected to reach USD 45.56 billion by 2028, exhibiting a CAGR of 5.9% during the forecast period. The market was valued at USD 29.24 billion in 2020 and is estimated to reach USD 30.56 billion in 2021. Rising commercial and residential infrastructure developments and extensive pump adoption in several applications are expected to boost market development. Fortune Business Insights™ mentions this information in its report titled “Centrifugal Pump Market, 2021-2028.” Centrifugal pumps are utilized to transfer liquids in bulk and provide...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.